Published in J Am Chem Soc on September 21, 2012
Improvements to robotics-inspired conformational sampling in rosetta. PLoS One (2013) 1.18
Design of activated serine-containing catalytic triads with atomic-level accuracy. Nat Chem Biol (2014) 0.96
Catalytic efficiency of designed catalytic proteins. Curr Opin Struct Biol (2014) 0.95
Impact of scaffold rigidity on the design and evolution of an artificial Diels-Alderase. Proc Natl Acad Sci U S A (2014) 0.94
A highly efficient cocaine-detoxifying enzyme obtained by computational design. Nat Commun (2014) 0.90
Intrinsic evolutionary constraints on protease structure, enzyme acylation, and the identity of the catalytic triad. Proc Natl Acad Sci U S A (2013) 0.89
Exploration of alternate catalytic mechanisms and optimization strategies for retroaldolase design. J Mol Biol (2013) 0.86
AbDesign: An algorithm for combinatorial backbone design guided by natural conformations and sequences. Proteins (2015) 0.86
Forcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family. ACS Synth Biol (2014) 0.85
Computational design of enone-binding proteins with catalytic activity for the Morita-Baylis-Hillman reaction. ACS Chem Biol (2013) 0.84
Installing hydrolytic activity into a completely de novo protein framework. Nat Chem (2016) 0.83
Recent advances in rational approaches for enzyme engineering. Comput Struct Biotechnol J (2012) 0.82
Systematic optimization model and algorithm for binding sequence selection in computational enzyme design. Protein Sci (2013) 0.79
Principles for designing proteins with cavities formed by curved β sheets. Science (2017) 0.78
Computational design of enzyme-ligand binding using a combined energy function and deterministic sequence optimization algorithm. J Mol Model (2015) 0.76
A fast loop-closure algorithm to accelerate residue matching in computational enzyme design. J Mol Model (2016) 0.76
Enzyme design: Functional Frankensteins. Nat Chem (2016) 0.75
OptZyme: computational enzyme redesign using transition state analogues. PLoS One (2013) 0.75
Use of an Improved Matching Algorithm to Select Scaffolds for Enzyme Design Based on a Complex Active Site Model. PLoS One (2016) 0.75
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81
Kemp elimination catalysts by computational enzyme design. Nature (2008) 8.19
De novo computational design of retro-aldol enzymes. Science (2008) 7.62
ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol (2011) 7.33
Serine protease mechanism and specificity. Chem Rev (2002) 5.46
Computational design of an enzyme catalyst for a stereoselective bimolecular Diels-Alder reaction. Science (2010) 4.32
Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature (2010) 4.04
Enzyme-like proteins by computational design. Proc Natl Acad Sci U S A (2001) 3.43
New algorithms and an in silico benchmark for computational enzyme design. Protein Sci (2006) 3.40
Dissecting the catalytic triad of a serine protease. Nature (1988) 3.19
RosettaLigand docking with full ligand and receptor flexibility. J Mol Biol (2008) 2.86
Assessing the performance of OMEGA with respect to retrieving bioactive conformations. J Mol Graph Model (2003) 2.78
Role of conformational sampling in computing mutation-induced changes in protein structure and stability. Proteins (2010) 2.56
Cysteine Proteases and Their Inhibitors. Chem Rev (1997) 2.29
PAPAIN-CATALYSED HYDROLYSIS OF SOME HIPPURIC ESTERS. A NEW MECHANISM FOR PAPAIN-CATALYSED HYDROLYSIS. Biochem J (1965) 2.28
Cytosolic phospholipase A2. J Lipid Mediat Cell Signal (1995) 2.21
RosettaHoles: rapid assessment of protein core packing for structure prediction, refinement, design, and validation. Protein Sci (2009) 1.96
Biomimetic Reactions Catalyzed by Cyclodextrins and Their Derivatives. Chem Rev (1998) 1.90
The catalytic role of the active site aspartic acid in serine proteases. Science (1987) 1.88
Site-directed mutagenesis and the role of the oxyanion hole in subtilisin. Proc Natl Acad Sci U S A (1986) 1.70
De novo enzyme design using Rosetta3. PLoS One (2011) 1.59
Theozymes and compuzymes: theoretical models for biological catalysis. Curr Opin Chem Biol (1998) 1.51
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci (Lond) (2005) 1.50
Exploring the active site of chorismate mutase by combinatorial mutagenesis and selection: the importance of electrostatic catalysis. Proc Natl Acad Sci U S A (1996) 1.43
Trends and innovations in industrial biocatalysis for the production of fine chemicals. Curr Opin Biotechnol (2004) 1.43
Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein (1996) 1.42
Structural and functional roles of asparagine 175 in the cysteine protease papain. J Biol Chem (1995) 1.40
Interconversion of ATP binding and conformational free energies by tryptophanyl-tRNA synthetase: structures of ATP bound to open and closed, pre-transition-state conformations. J Mol Biol (2003) 1.39
Proteases and protease inhibitors in tumor progression. Adv Exp Med Biol (1997) 1.27
Structural reorganization and preorganization in enzyme active sites: comparisons of experimental and theoretically ideal active site geometries in the multistep serine esterase reaction cycle. J Am Chem Soc (2008) 1.25
Induction of an antibody that catalyzes the hydrolysis of an amide bond. Science (1988) 1.19
Evaluation and ranking of enzyme designs. Protein Sci (2010) 1.14
Probing the mechanism and improving the rate of substrate-assisted catalysis in subtilisin BPN'. Biochemistry (1991) 1.10
Molecular dynamics simulations of the catalytic pathway of a cysteine protease: a combined QM/MM study of human cathepsin K. J Am Chem Soc (2007) 1.04
Multiple active site corrections for docking and virtual screening. J Med Chem (2004) 1.04
Quantum mechanical design of enzyme active sites. J Org Chem (2008) 1.02
Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies. Proc Natl Acad Sci U S A (1995) 0.98
Specific recognition of saturated and 4,5-unsaturated hexuronate sugars by a periplasmic binding protein involved in pectin catabolism. J Mol Biol (2007) 0.95
Site-directed mutagenesis of a catalytic antibody: an arginine and a histidine residue play key roles. Biochemistry (1994) 0.95
Enzyme catalysis by hydrogen bonds: the balance between transition state binding and substrate binding in oxyanion holes. J Org Chem (2010) 0.95
Dissection of an antibody-catalyzed reaction. Proc Natl Acad Sci U S A (1994) 0.91
A genetic approach to the generation of antibodies with enhanced catalytic activities. Proc Natl Acad Sci U S A (1993) 0.88
Hydrolytic antibodies: variations on a theme. Chem Biol (1996) 0.88
Improved beta-lactam acylases and their use as industrial biocatalysts. Curr Opin Biotechnol (2004) 0.86
Catalytic antibodies as designer proteases and esterases. Chem Rev (2002) 0.85
Demonstration of a change in the rate-determining step in papain- and ficin-catalyzed acyl-transfer reactions. Biochemistry (1971) 0.83
Tour de paclitaxel: biocatalysis for semisynthesis. Annu Rev Microbiol (1998) 0.80
Design of a novel globular protein fold with atomic-level accuracy. Science (2003) 13.06
Protein structure prediction using Rosetta. Methods Enzymol (2004) 12.05
Predicting protein structures with a multiplayer online game. Nature (2010) 9.95
Toward high-resolution de novo structure prediction for small proteins. Science (2005) 9.18
Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. J Mol Biol (2003) 8.35
Macromolecular modeling with rosetta. Annu Rev Biochem (2008) 8.32
Kemp elimination catalysts by computational enzyme design. Nature (2008) 8.19
Evaluation of structural and evolutionary contributions to deleterious mutation prediction. J Mol Biol (2002) 7.79
High-resolution structure prediction and the crystallographic phase problem. Nature (2007) 7.67
De novo computational design of retro-aldol enzymes. Science (2008) 7.62
Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res (2004) 7.39
ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol (2011) 7.33
Consistent blind protein structure generation from NMR chemical shift data. Proc Natl Acad Sci U S A (2008) 6.76
A simple physical model for binding energy hot spots in protein-protein complexes. Proc Natl Acad Sci U S A (2002) 6.18
Evaluating protein structures determined by structural genomics consortia. Proteins (2007) 5.45
Crystal structure of a monomeric retroviral protease solved by protein folding game players. Nat Struct Mol Biol (2011) 5.02
Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem (2009) 4.95
ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell (2002) 4.79
Towards robust regional estimates of CO2 sources and sinks using atmospheric transport models. Nature (2002) 4.71
An orientation-dependent hydrogen bonding potential improves prediction of specificity and structure for proteins and protein-protein complexes. J Mol Biol (2003) 4.63
Assigning function to yeast proteins by integration of technologies. Mol Cell (2003) 4.58
Ca2+ indicators based on computationally redesigned calmodulin-peptide pairs. Chem Biol (2006) 4.52
Protein NMR recall, precision, and F-measure scores (RPF scores): structure quality assessment measures based on information retrieval statistics. J Am Chem Soc (2005) 4.43
Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science (2011) 4.42
Protein-protein docking with backbone flexibility. J Mol Biol (2007) 4.32
Computational design of an enzyme catalyst for a stereoselective bimolecular Diels-Alder reaction. Science (2010) 4.32
Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins (2009) 4.27
Computational redesign of endonuclease DNA binding and cleavage specificity. Nature (2006) 4.06
Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature (2010) 4.04
Protein production and purification. Nat Methods (2008) 3.97
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat Struct Biol (2002) 3.92
Hierarchical self-assembly of DNA into symmetric supramolecular polyhedra. Nature (2008) 3.92
Automated de novo prediction of native-like RNA tertiary structures. Proc Natl Acad Sci U S A (2007) 3.87
Algorithm discovery by protein folding game players. Proc Natl Acad Sci U S A (2011) 3.74
Computational redesign of protein-protein interaction specificity. Nat Struct Mol Biol (2004) 3.66
Modeling structurally variable regions in homologous proteins with rosetta. Proteins (2004) 3.64
Structure prediction for CASP8 with all-atom refinement using Rosetta. Proteins (2009) 3.64
ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility. Proteins (2006) 3.60
Rational HIV immunogen design to target specific germline B cell receptors. Science (2013) 3.55
High-resolution mapping of protein sequence-function relationships. Nat Methods (2010) 3.47
Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature (2006) 3.45
Computational alanine scanning of protein-protein interfaces. Sci STKE (2004) 3.41
Automated prediction of CASP-5 structures using the Robetta server. Proteins (2003) 3.41
New algorithms and an in silico benchmark for computational enzyme design. Protein Sci (2006) 3.40
Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J (2003) 3.35
Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial. Clin Infect Dis (2009) 3.32
Inflammation in neurodegenerative diseases. Immunology (2010) 3.22
An engineered microbial platform for direct biofuel production from brown macroalgae. Science (2012) 3.20
A large scale test of computational protein design: folding and stability of nine completely redesigned globular proteins. J Mol Biol (2003) 3.08
Atomic accuracy in predicting and designing noncanonical RNA structure. Nat Methods (2010) 3.07
Progress in modeling of protein structures and interactions. Science (2005) 3.05
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A (2009) 3.01
Structure prediction for CASP7 targets using extensive all-atom refinement with Rosetta@home. Proteins (2007) 3.01
NMR structure determination for larger proteins using backbone-only data. Science (2010) 3.00
Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease. Nature (2006) 2.95
Refinement of protein structures into low-resolution density maps using rosetta. J Mol Biol (2009) 2.94
PubNet: a flexible system for visualizing literature derived networks. Genome Biol (2005) 2.89
The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci U S A (2006) 2.88
De novo prediction of three-dimensional structures for major protein families. J Mol Biol (2002) 2.88
RosettaLigand docking with full ligand and receptor flexibility. J Mol Biol (2008) 2.86
Voltage sensor conformations in the open and closed states in ROSETTA structural models of K(+) channels. Proc Natl Acad Sci U S A (2006) 2.81
Multipass membrane protein structure prediction using Rosetta. Proteins (2006) 2.79
Computational thermostabilization of an enzyme. Science (2005) 2.79
Rosetta predictions in CASP5: successes, failures, and prospects for complete automation. Proteins (2003) 2.77
Improved molecular replacement by density- and energy-guided protein structure optimization. Nature (2011) 2.74
Improved side-chain modeling for protein-protein docking. Protein Sci (2005) 2.72
Close agreement between the orientation dependence of hydrogen bonds observed in protein structures and quantum mechanical calculations. Proc Natl Acad Sci U S A (2004) 2.71
Elicitation of structure-specific antibodies by epitope scaffolds. Proc Natl Acad Sci U S A (2010) 2.68
Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem (2004) 2.66
Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters. J Biol Chem (2002) 2.64
Cold-shock induced high-yield protein production in Escherichia coli. Nat Biotechnol (2004) 2.62
Role of conformational sampling in computing mutation-induced changes in protein structure and stability. Proteins (2010) 2.56
Robotic cloning and Protein Production Platform of the Northeast Structural Genomics Consortium. Methods Enzymol (2005) 2.54
CASD-NMR: critical assessment of automated structure determination by NMR. Nat Methods (2009) 2.50
A vast repertoire of Dscam binding specificities arises from modular interactions of variable Ig domains. Cell (2007) 2.50
Principles for designing ideal protein structures. Nature (2012) 2.50
Solution structure of a minor and transiently formed state of a T4 lysozyme mutant. Nature (2011) 2.49
Physically realistic homology models built with ROSETTA can be more accurate than their templates. Proc Natl Acad Sci U S A (2006) 2.47
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature (2011) 2.46
Protein-DNA binding specificity predictions with structural models. Nucleic Acids Res (2005) 2.45
De novo protein structure generation from incomplete chemical shift assignments. J Biomol NMR (2008) 2.43
Assessing the utility of coevolution-based residue-residue contact predictions in a sequence- and structure-rich era. Proc Natl Acad Sci U S A (2013) 2.43
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial. Lancet (2004) 2.43
The structural basis of cyclic diguanylate signal transduction by PilZ domains. EMBO J (2007) 2.39
Computational design of protein-protein interactions. Curr Opin Chem Biol (2004) 2.39